MarketInOut Stock Screener Log In | Sign Up

GlaxoSmithKline Pharmaceuticals Ltd

BSE • Healthcare • Drug Manufacturers - General • Quote as of 10/28/2026 10:01
GlaxoSmithKline Pharmaceuticals Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeBSE
Market Capitalization407,388 mln
Float41.29 mln
Earnings Date11/03/2026

EPS

56.30
Exceptional

P / E

43.93
High premium

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.6
Likely reliable

Relative Strength

69 / 100
Outperforming

Debt / Equity

0.02
Debt-free

Business Description

GlaxoSmithKline Pharmaceuticals Limited is a Mumbai-based company founded in 1924 that makes and sells a wide range of medical products across India and global markets. Its portfolio includes vaccines that protect against serious diseases such as influenza, hepatitis, meningitis, and chickenpox, as well as treatments for respiratory conditions like asthma and chronic obstructive pulmonary disease. The company also offers everyday medicines covering antibiotics, skin treatments, pain relief, thyroid support, and vitamins.

Key Fundamentals

EPS56.30
P/E43.93
ROE54.07
RPS219
ROIC69.83
ROA26.43
Interest Cover396
EBITDA, mln15,195
EV / EBITDA29.27
EV / EBIT30.61
Revenue, mln39,549
EV / Revenue11.24

Quote Details

Last 2,491.30
Change 39.8 (1.62%)
Open 2,451.50
Volume 162
Turnover 403,591
Average Volume 3,264.67

Financial Ratios

Pre-Tax Profit Margin37
Current Ratio2.03
Price / Book20.67
Price / Tangible Book20.74
Price / Cash Flow222
Price / Free Cash Flow48.62
Debt / Equity0.02
Price / Sales11.86
PEG Ratio2.18

Financial Strength

Altman Z-Score16.67
Piotroski F-Score 5 / 9
Beneish M-Score-2.6
Price to Intrinsic Value3.87
Price to Lynch Fair Value2.43
Price to Graham Number6.43
Shiller PE Ratio53.50

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 1.12% 74 / 100   
1 Month -11.47% 33 / 100   
2 Months 0.07% 70 / 100   
6 Months 4.69% 69 / 100   
1 Year -7.01% 62 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog